Infinity Pharmaceuticals, Inc.
NASDAQ: INFI
$0.61
-$0.03 (-4.5%)
Closing price January 30, 2023
Monday's top analyst upgrades and downgrades included Baker Hughes, Bloomin' Brands, DoorDash, Estee Lauder, First Solar, Levi Strauss, Lyft, Mondelez and Yeti.
1 year ago
Last Updated: 1 year ago
These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. They are not penny stocks with no track record or liquidity, and...
1 year ago
Last Updated: 1 year ago
Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, Chewy, Juniper Networks, MGM Resorts, Microsoft, Salesforce.com, Sony, Teladoc and Virgin Galactic.
1 year ago
Last Updated: 1 year ago
Here are five biotech stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, these are not penny...
1 year ago
Last Updated: 1 year ago
Here are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. They are not penny stocks with absolutely no track record or...
1 year ago
Thursday's top analyst upgrades and downgrades included Agilent Technologies, Carnival, Clorox, Darden Restaurants, Pinduoduo, QuantumScape, Royal Dutch Shell and Williams-Sonoma.
1 year ago
Last Updated: 1 year ago
Here are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. They are not penny stocks with absolutely no track record or...
1 year ago
Last Updated: 1 year ago
Thursday's top analyst upgrades and downgrades included CrowdStrike, Honda, KB Home, McAfee, STMicroelectronics, Tilray and Wells Fargo.
1 year ago
Last Updated: 1 year ago
The Friday afternoon analyst calls were focused on Biogen, Fortinet, Pinterest, Snap and more.
1 year ago
Last Updated: 1 year ago
Infinity Pharmaceuticals shares made a healthy gain early on Tuesday after the firm announced a clinical collaboration with Arcus Biosciences.
4 years ago
Last Updated: 3 years ago
24/7 Wall St. has collected a few pharma and biotech catalysts that are coming up on the calendar in November and December.
5 years ago
Last Updated: 5 years ago
24/7 Wall St. has compiled 10 of the top business news items, where there was specific company news driving the shares, for the week ended Friday, October 13, 2017.
5 years ago
Last Updated: 3 years ago
Infinity Pharmaceuticals saw its shares almost double early on Thursday after the company announced good news.
5 years ago
Last Updated: 3 years ago
The top analyst upgrades, downgrades and other research calls from Thursday include Ardelyx, Juniper, Kroger, Phillips 66, Square, Transocean and Walmart.
5 years ago
Last Updated: 2 years ago
The volume of insider activity has started to dry up as we get closer to the fourth-quarter earnings reports, and as usual, it could stay low most of the month of January.
6 years ago
Last Updated: 3 years ago